Interpace Diagnostics Group Stock News

In-network status for ThyGeNEXT® and ThyraMIR® with State's Largest Payer

PARSIPPANY, NJ, Jan. 20, 2021 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (NASDAQ: IDXG) announced today that it will hold its third quarter 2020 financial results conference call and webcast afte

Conference Call and Webcast Thursday January 21, 2021 at 4:30 pm ET

Parsippany, NJ, Nov. 25, 2020 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (NASDAQ: IDXG) today announced that Jack Stover, President & Chief Executive Officer, will retire effective December 31, 2

PARSIPPANY, NJ, Nov. 19, 2020 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (“Interpace” or the “Company”) (NASDAQ: IDXG) on November 18, 2020 received notice from the Listing Qualifications

Interpace Biosciences, Inc. (NASDAQ:IDXG) shares gapped up prior to trading on Wednesday . The stock had previously closed at $2.98, but opened at $3.56. Interpace Biosciences shares last traded at $4

Wall Street analysts forecast that Interpace Diagnostics Group Inc (NASDAQ:IDXG) will post earnings of ($1.64) per share for the current quarter, according to Zacks. Two analysts have issued estimates

The

Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 18) Avenue Therapeutics Inc (NASDAQ: ATXI) Checkmate Pharmaceuticals Inc (NASDAQ: CMPI) DarioHealth Corp (NASDAQ:...

Clovis reports positive data from TRITON clinical trial. Interpace Biosciences sinks on potential compliance roadblocks.

The

LMNX earnings call for the period ending June 30, 2020.

QIAGEN reports full results for second quarter and first half of 2020

Podium Presentation Accepted for the American Society of Cytopathology (ASC) Annual Meeting PARSIPPANY, NJ, July 21, 2020 -- Interpace Biosciences, Inc. (NASDAQ: IDXG).

The